Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.

Teva Pharmaceutical Industries (NYSE:TEVA) reported first-quarter 2026 results that management said reflect continued ...

Teva Pharmaceutical Industries (NYSE:TEVA) reported first-quarter 2026 results that management said reflected continued ...

Blackstone committed $400 million to fund development of Teva's promising autoimmune disease drug duvakitug. This deal ...

The Federal Circuit recently clarified its written description jurisprudence concerning claims directed to methods of using a ...

For an accessible version of this Press Release, please visit Q1 2026 revenues of ~$4.0 billion increased by 2% in U.S.

Teva Pharmaceuticals has struck a deal to buy Emalex Biosciences for $700 million | Teva Pharmaceuticals has struck a deal to ...

Teva Pharmaceutical Industries (NYSE: TEVA) will unveil its first-quarter results this Wednesday, April 29. Many Teva ...

By Siddhi Mahatole April 29 (Reuters) - Teva Pharmaceutical beat first-quarter profit estimates on Wednesday as growth in its ...

A federal appeals court judge appeared skeptical Tuesday of a lawsuit from Teva Pharmaceuticals Inc. challenging the US ...

Teva exceeded all sustainability-linked bond targets, linking financial performance to expanded patient access to medicines and reduced ...

Teva (TEVA) stock jumps as the company exceeds forecasts with Q1 2026 financials. However, it cut its 2026 earnings outlook ...